Human leukocytes in the tumor are most likely originated from the engrafted donor CD34+ cell, as several groups have demonstrated the loss of tumor-infiltrating immune cells in the process of PDX expansion in non-humanized mice [27,28,29]. Here, CD34 is linked to neoplasm.